Louisiana State Employees Retirement System trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,100 shares of the medical equipment provider’s stock after selling 200 shares during the period. Intuitive Surgical comprises about 0.4% of Louisiana State Employees Retirement System’s holdings, making the stock its 24th biggest holding. Louisiana State Employees Retirement System’s holdings in Intuitive Surgical were worth $24,508,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $30,000. TD Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Price Performance
ISRG opened at $440.94 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The business has a 50-day moving average of $461.55 and a 200-day moving average of $499.41. The company has a market capitalization of $158.07 billion, a PE ratio of 61.50, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on ISRG shares. Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Piper Sandler reissued an “overweight” rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $589.43.
View Our Latest Research Report on ISRG
Insider Activity
In other news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- High Dividend REITs: Are They an Ideal Way to Diversify?
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Consumer Discretionary Stocks Explained
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- What is a Stock Market Index and How Do You Use Them?
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
